RT Book, Section A1 Schwinghammer, Terry L. A1 DiPiro, Joseph T. A1 Ellingrod, Vicki L. A1 DiPiro, Cecily V. SR Print(0) ID 1178899272 T1 Drug Allergy T2 Pharmacotherapy Handbook, 11e YR 2021 FD 2021 PB McGraw Hill PP New York, NY SN 9781260116694 LK accesspharmacy.mhmedical.com/content.aspx?aid=1178899272 RD 2024/04/23 AB Table Graphic Jump LocationTABLE A4-1Classification of Allergic Drug ReactionsView Table||Download (.pdf)TABLE A4-1Classification of Allergic Drug ReactionsTypeDescriptorCharacteristicsTypical OnsetDrug CausesIImmediate (IgE mediated)Allergen binds to IgE on basophils or mast cells, resulting in release of inflammatory mediatorsWithin 1 hour (may be within 1–6 hours)Penicillin anaphylaxis, angioedemaBlood productsPolypeptide hormonesVaccinesDextranIIDelayed; cytotoxicCell destruction occurs because of cell-associated antigen that initiates cytolysis by antigen-specific antibody (IgG) and complement. Most often involves blood elementsTypically >72 hours to weeksPenicillin, quinidine, quinine, heparin, thiouracils, sulfonamides, methyldopaIIIDelayed; immune complexAntigen–antibody (IgG or IgM) complexes form and deposit on blood vessel walls and activate complement. Result is a serum sickness-like syndrome or vasculitis>72 hours to weeksPenicillins, sulfonamides, minocycline, hydantoinsIVDelayed; T cell–mediatedAntigens cause activation of T lymphocytes, which release cytokines and recruit effector cells>72 hoursIVaTh1 cells, interferon-γ, monocytes, and eosinophils respond to the antigen1–21 daysTuberculin reaction, contact dermatitisIVbTh2 cells, interleukin-4, and interleukin-5 respond to the antigen1–6 weeksMaculopapular rashes with eosinophiliaIVcCytotoxic T cells, perforin, granzyme B, FasL respond to the antigen4–28 daysBullous exanthems; fixed drug eruptionsIVdT cells and interleukin-8 respond to the antigen>72 hoursAcute generalized exanthematous pustulosis